Disease Control Data, nr-axSpA

Review separate clinical trial data relating to the efficacy of RINVOQ® in non-radiographic axial spondyloarthritis patients. See Important Safety Info, including BOXED WARNING, and full Prescribing Info.

Maybe It's NOT Mechanical Back Pain : Clinical Resource

Axial Spondyloarthritis RINVOQ® (upadacitinib)

Disease Control Data, nr-axSpA

FDA Approval Of The First nr-AxSpA Biologics Projecting Regulatory Market Dynamics

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

JCM, Free Full-Text

Building a Treatment Plan for active Non-radiographic Axial Spondyloarthritis (nr-axSpA)

Association of circulating calprotectin with lipid profile in axial spondyloarthritis

Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis